At what enterprise value was CORONARIA HOIVA acquired in 2019?

During the acquisition of CORONARIA HOIVA by HUMANA in 2019, the transaction's Enterprise Value is estimated to be in the range of 50M - 150M EUR.

What was the EV/EBITDA of CORONARIA HOIVA when it was acquired by HUMANA?

The estimated EV/EBITDA multiple for CORONARIA HOIVA is in the range of 15x - 25x.

When was CORONARIA HOIVA acquired by HUMANA?

CORONARIA HOIVA was acquired by HUMANA in 2019.

What was the revenue of CORONARIA HOIVA at the time of the deal?

The revenue of CORONARIA HOIVA at the time of the deal is estimated to be in the range of 50M - 100M EUR.

What was the EBITDA of CORONARIA HOIVA during the acquisition?

CORONARIA HOIVA's EBITDA is estimated to be in the range of 0M - 5M EUR.

How is the data for the CORONARIA HOIVA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the CORONARIA HOIVA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.marketscreener.com/quote/stock/HUMANA-AB-27506429/news/Humana-AB-OM-HUM-completed-the-acquisition-of-Coronaria-Hoiva-Oy-from-Coronaria-Oy-and-CapMan-Grow-34348103/

← DATABASE

Home Database Healthcare & PharmaCORONARIA HOIVA

01/2019

CORONARIA HOIVA acquired by HUMANA

FINLAND Health Providers / Healthcare Facilities / Nursing Homes EV 50M - 150M EUR

Context

Humana AB entered into a definitive agreement to acquire 100% of Coronaria Hoiva Oy to significantly expand its operational footprint in the Finnish market. This strategic acquisition was designed to integrate Coronaria Hoiva’s specialized residential care portfolio into Humana’s existing Finnish operations, creating a more diversified and robust platform for social care delivery. The transaction was financed through a combination of existing cash reserves and new credit facilities, and it received formal approval from the Finnish Competition and Consumer Authority in early April. The move aligned with Humana’s long-term strategy of consolidating the Nordic care market, providing an immediate positive contribution to the group's revenues and earnings per share while enhancing its ability to serve the growing Finnish aging population.

CORONARIA HOIVA, which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Coronaria Hoiva Oy functions as a prominent Finnish provider of social care services, specializing in residential care for the elderly, individuals with disabilities, and mental health rehabilitation. At the time of the transaction, the company operated a high-quality network of care homes across Finland, maintaining a strong reputation for clinical excellence and personalized service delivery.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
04/2019	COLISÉE	ARMONEA	BELGIUM	Nursing Homes
03/2019	DOMUSVI	RESIDALYA	FRANCE	Nursing Homes
04/2018	INVESTINDUSTRIAL	LIFEBRAIN	ITALY	Labs (Biology)
03/2018	ICV PARTNERS	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Radiology
03/2018	THE ADOLFSEN GROUP	FRÖSUNDA	SWEDEN	Healthcare Facilities
01/2018	PERMIRA	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
06/2017	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Nursing Homes
04/2017	EQT PARTNERS	COLISÉE	FRANCE	Nursing Homes
01/2017	PARTNERS GROUP / PSP INVESTMENTS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
01/2017	MARS	VCA	UNITED STATES	Vet Clinics

REFERENCES

Valuation range: EV 50M - 150M EUR

Revenue range: 50M - 100M EUR

EBITDA range: 0M - 5M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CORONARIA HOIVA by HUMANA are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: humana